MedTrace Logo

The Trio Laser Module for Hair Removal Treatment

NCT04599751 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2021-11-17

No results posted yet for this study

Summary

The study is aimed to assess the safety and efficacy of hair removal treatments, using the Trio Laser Module (Alma Lasers).

The study will include 36 subjects that will undergo axilla and bikini line hair removal treatments. Safety and efficacy will be evaluated 3- months after the last treatment.

Conditions

  • Hair Removal Treatment

Interventions

DEVICE

Hair removal treatment

Axilla and bikini line hair removal treatments using the Trio Laser Module (Alma Lasers).

Sponsors & Collaborators

  • Alma Lasers

    lead INDUSTRY

Principal Investigators

  • Michael Gold, MD · Tennessee Clinical Research Center

  • Edwardo Weiss, MD · Skin Care Research, LLC

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-07
Primary Completion
2021-10-07
Completion
2021-11-16
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04599751 on ClinicalTrials.gov